Drug maker Alkem Laboratories Ltd and diagnostics chain Dr Lal Pathlabs, which launched their initial public offerings (IPO) on Tuesday, saw their share sales subscribed fully at the end of the second day of their offerings, according to data from stock exchanges.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
